Table 5.
Comparison between the studied groups according to the level of MDA
| MDA (nmol/ml) | Control group (n = 15) | TBT treated group (n = 15) | TBT + GTE group (n = 15) | F | p |
|---|---|---|---|---|---|
| Min. – Max. | 11.60–37.80 | 50.30–65.20 | 40.40–50.40 | 98.915* | <0.001* |
| Mean ± SD. | 29.81 ± 7.19 | 57.57 ± 5.28 | 46.20 ± 3.02 | ||
| Median | 32.70 | 55.70 | 47.10 | ||
| Significance between groups | p1 < 0.001*, p2 < 0.001*, p3 < 0.001* | ||||
F: F test (ANOVA), Significance between groups was done using Post Hoc Test (LSD)
p1: p value for comparing between Control and TBT treated groups
p2: p value for comparing between Control and TBT + GTEgroups
p3: p value for comparing between TBT treated and TBT + GTEgroups
* Statistically significant at p ≤ 0.05